Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Okay enough election chatter

<< Previous

Bullboard Posts

Next >>

Comment by Arrakis37on Nov 08, 2020 9:07am

78 Views

Post# 31859176

RE:Okay enough election chatter

My guess

Right now, the real value of this company should be between 75-100 M$. Very high risk because of the lack of transparency from Thomvest and no serious coverage by reputable analysts